Abstract
Executive Summary
Leukemia includes a broad variety of histological separate disorders which
make the leukemia market segmented. There are today more than 240 therapeutics
targeting leukemia, from early preclinical to marketed drugs. Leukemia Drug
Pipeline Update lists all drugs and gives you a progress analysis on each one
of them. Identified drugs are linked to 132 different targets. These targets
are further categorized on the CD-ROM by 46 classifications of molecular
function and with pathway referals to BioCarta, KEGG and NetPath. Read more
below on how the Leukemia Drug Pipeline Update is organized.
How May Drug Pipeline Update Be of Use?
- Show investors/board/management that you are right on top of drug
development progress in your therapeutic area.
- Find competitors, collaborations partners, M&A candidates etc.
- Jump start competitive drug intelligence operations
- Excellent starting point for world wide benchmarking
- Compare portfolio and therapy focus with your peers
- Speed up pro-active in-/out licensing strategy work
- Fast and easy way of tracking drugs using search engines; just one click
from inside the application and you may search the World Wide Web and PubMed
for any drug.
View Cart
